نتایج جستجو برای: لوسمی لنفوسیتی مزمن cll

تعداد نتایج: 15736  

Journal: :Blood 2011
Susan L Slager Kari G Rabe Sara J Achenbach Celine M Vachon Lynn R Goldin Sara S Strom Mark C Lanasa Logan G Spector Laura Z Rassenti Jose F Leis Nicola J Camp Martha Glenn Neil E Kay Julie M Cunningham Curtis A Hanson Gerald E Marti J Brice Weinberg Vicki A Morrison Brian K Link Timothy G Call Neil E Caporaso James R Cerhan

Prior genome-wide association (GWA) studies have identified 10 susceptibility loci for risk of chronic lymphocytic leukemia (CLL). To identify additional loci, we performed a GWA study in 407 CLL cases (of which 102 had a family history of CLL) and 296 controls. Moreover, given the strong familial risk of CLL, we further subset our GWA analysis to the CLL cases with a family history of CLL to i...

Journal: :Cancer research 2012
Karrie K Wong Fred Brenneman Alden Chesney David E Spaner Reginald M Gorczynski

CD200 is a transmembrane molecule with an important immunoregulatory role that is overexpressed on most chronic lymphocytic leukemia (CLL) cells. In this study, we characterized a previously unknown soluble form of this molecule in human plasma termed sCD200. Levels of sCD200 were elevated in the plasma of patients with CLL as compared with healthy controls, and there was a significant correlat...

Journal: :Postepy higieny i medycyny doswiadczalnej 2013
Marta Karp Krzysztof Giannopoulos

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. The mechanism the mechanism of the disease development still remains unrevealed. In recent years new unique molecular and clinical features of CLL have emerged leading to a unified hypothesis of CLL origin. Major progress in understanding CLL biology was made after identification of mutational status of immunog...

Journal: :Blood 1992
D F Friedman J S Moore J Erikson J Manz J Goldman P C Nowell L E Silberstein

Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought to arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotype-switched B-CLL as a potentially more differentiated variant, we performed genetic and functional immunoglobulin (Ig) gene analysis in two cases of CD5+ B-CLL in which t...

2003
Guillaume Dighiero Philippe Travade Sylvie Chevret Pierrft Fenaux Claude Chastang

INCE TURKS’ initial identification of chronic lymphoS cytic leukemia (CLL), Minot and Isaacs” description of its clinical features in 1924, and Dameshek‘? hypothesis in 1967, considerable progress in the understanding of CLL has been achieved, especially during the last two decades. The purpose of the present work is to review the major advances in the biology and clinical research of CLL and t...

Journal: :Blood 1999
R Buhmann A Nolte D Westhaus B Emmerich M Hallek

Although spontaneous remissions may rarely occur in B-cell chronic lymphocytic leukemia (B-CLL), T cells do generally not develop a clinically significant response against B-CLL cells. Because this T-cell anergy against B-CLL cells may be caused by the inability of B-CLL cells to present tumor-antigens efficiently, we examined the possibility of upregulating critical costimulatory (B7-1 and B7-...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013
Susan L Slager Sara J Achenbach Yan W Asmann Nicola J Camp Kari G Rabe Lynn R Goldin Timothy G Call Tait D Shanafelt Neil E Kay Julie M Cunningham Alice H Wang J Brice Weinberg Aaron D Norman Brian K Link Jose F Leis Celine M Vachon Mark C Lanasa Neil E Caporaso Anne J Novak James R Cerhan

BACKGROUND Our genome-wide association study (GWAS) of chronic lymphocytic leukemia (CLL) identified 4 highly correlated intronic variants within the IRF8 gene that were associated with CLL. These results were further supported by a recent meta-analysis of our GWAS with two other GWAS of CLL, supporting the IRF8 gene as a strong candidate for CLL risk. METHODS To refine the genetic associatio...

Journal: :Hematological Oncology 2023

Chronic lymphocytic leukemia (CLL) patients with hepatitis B virus (HBV) infection have a poor prognosis, underlying mechanism remains unclear. NOTCH mutations are frequent in CLL and associated disease progression drug resistance. It is also reported to be lymphoid malignancies. In order investigate the relation between pathway HBV-associated CLL, we studied 98 previously untreated HBV positiv...

Journal: :Blood 1990
F Santiago-Schwarz C Panagiotopoulos A Sawitsky K R Rai

We show that lymphokine-activated killer (LAK) cell precursors derived from patients with B-cell chronic lymphocytic leukemia (B-CLL) and cultured in the presence of recombinant interleukin-2 and normal human serum (NHS), develop into primarily NK cell-like (CD 57+) LAK cells, whereas identically prepared LAK cell precursors from normal subjects develop into mainly T cell-like (CD 3+, CD 8+) LA...

2015
Jitra Kriangkum Sarah N. Motz Tanner Mack Sara Beiggi Eva Baigorri Hemalatha Kuppusamy Andrew R. Belch James B. Johnston Linda M. Pilarski Derya Unutmaz

The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Single-cell PCR analysis and next-generation immuno-sequencing identified IGH-defined clones. In 23% ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید